Startups
Newleos Therapeutics
Newleos Therapeutics is a Boston-based clinical-stage neuroscience biotechnology company developing oral medicines for neuropsychiatric disorders. Its Roche-licensed pipeline includes NTX-1955, targeting GABAA-γ1 for generalized anxiety; NTX-1472, a V1a antagonist being studied in social anxiety; NTX-2001 (ralmitaront), a TAAR1 partial agonist being studied in substance use disorders; and NTX-1511 (basmisanil), targeting GABAA-α5 for cognitive impairment. These are investigational therapies, with efficacy and safety subject to clinical testing. Founded by Longwood Fund and neuroscience drug-development specialists Federico Bolognani and William Martin, Newleos launched publicly in February 2025 with a USD93.5 million Series A led by Goldman Sachs Alternatives. Timothy Noyes is current CEO, Federico Bolognani is co-founder and CMO, and Rohan Palekar became board chairman in July 2026. Christoph Westphal continues as a director after stepping down as executive chairman.
Team
 Adam SimmonsVice President, Clinical Operations & Development |
 Brian SheaVice President, Head of Legal |
 Chris JepsenVice President, Quality |
 Christoph WestphalCo-founder and Board Director |
 Dr. John HamerBoard Observer |
 Federico BolognaniCo-founder, Chief Medical Officer |
 Gerard SanacoraScientific Advisory Board Member |
 Hector GuzmanVice President, CMC and Technical Operations |
 Jennifer GervasiVice President, Program Management |
 John McCabeChief Financial Officer |
 Juliane HellhammerClinical Advisory Board Member |
 Kyle AudiVice President, Finance |
 Lea HachigianSenior Vice President, Corporate Strategy and Operations |
 Marcelo GutiérrezVice President, Clinical Pharmacology |
 Maurizio FavaScientific Advisory Board Member |
 Michael LiebowitzClinical Advisory Board Member |
 Ming CheahBoard Director |
 Murray SteinClinical Advisory Board Member |
 Pini OrbachBoard Observer |
 Raymond CamahortBoard Director |
 Rohan PalekarChairman |
 Sanjay MathewClinical Advisory Board Member |
 Seth HopkinsVice President, Clinical Translational Medicine |
 Sondra SmyrniosSenior Vice President, Clinical and Technical Operations |
 Tiffany LagoVice President, Clinical Development |
 Timothy NoyesChief Executive Officer · Board Director |